Typically occurring in older adults, cardiac arrhythmias will only increase in frequency as the population ages.1 In fact, an estimated 33.5 million people worldwide have atrial fibrillation (AF), the most common type of cardiac arrhythmia.2 These numbers are serious, and so are the possible consequences for people with AF. Atrial fibrillation may lead to heart failure and can be life-threatening—AF patients are five times more likely to suffer a stroke than other patients, and the cost of treatment is estimated in the billions of dollars.3 Ventricular tachycardia (VT) and ventricular fibrillation (VF) pose even more of a concern. Sustained VT is a fatal disease, and it is estimated that almost 4 million people lose their lives annually due to sudden cardiac death worldwide, with about half of those deaths attributed to VT.4
With clinical- and evidence-based expertise in cardiac arrhythmias, we offer unparalleled solutions. Our devices are designed to enhance the health and well-being of patients by providing:
- Proactive care
- Early intervention
- Revolutionary treatment technologies
In addition, they uniquely support hospitals’ and clinics’ operational efficiencies and cost-management needs.
Our integrated diagnostic and therapeutic solutions include: technologically advanced ablation catheters; imaging, mapping and navigation systems; remote monitoring devices; and implantable devices, including the world’s first commercially available leadless pacemaker.*